TownSquare Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,246
Closed -$287K 1064
2025
Q1
$287K Buy
2,246
+592
+36% +$80.3K ﹤0.01% 1372
2024
Q4
$219K Sell
1,654
-29
-2% -$4.08K ﹤0.01% 1405
2024
Q3
$245K Buy
1,683
+154
+10% +$22.3K ﹤0.01% 1277
2024
Q2
$210K Sell
1,529
-9
-0.6% -$1.2K ﹤0.01% 1193
2024
Q1
$211K Buy
+1,538
New +$210K ﹤0.01% 1129
2020
Q3
Sell
-3,684
Closed -$506K 445
2020
Q2
$506K Sell
3,684
-817
-18% -$104K 0.03% 284
2020
Q1
$544K Sell
4,501
-1,301
-22% -$150K 0.04% 264
2019
Q4
$699K Sell
5,802
-101
-2% -$11.3K 0.06% 232
2019
Q3
$640K Buy
5,903
+1,357
+30% +$142K 0.05% 255
2019
Q2
$478K Buy
4,546
+1,124
+33% +$120K 0.05% 276
2019
Q1
$383K Buy
+3,422
New +$375K 0.03% 319

Other funds holding IBB

TownSquare Capital's IBB Position: Q2 2025 in Review

TownSquare Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 2,246 shares — an estimated $287K sold.

TownSquare Capital first reported a position in IBB in Q1 2019 and held it in 11 quarters. The position peaked at $699K in Q4 2019. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • TownSquare Capital reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 2,246 iShares Biotechnology ETF shares in Q2 2025, an estimated $287K.
  • TownSquare Capital first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 11 quarters.
  • TownSquare Capital's iShares Biotechnology ETF position peaked at $699K in Q4 2019.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.